Saturday 17 October 2026
Export UTMD’s income statement to Excel — free account
Utah Medical Products, Inc.
UTMD Healthcare Medical Instruments & Supplies
Utah Medical Products, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, down 5.83% from fiscal 2024. In the quarter to June 2026, revenue fell 14.3%, EPS fell 10.6% and free cash flow fell 55.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years.
74.51
0.41
−0.55%
Follow UTMD
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 6 | 7 | 9 | 6 | 8 | 5 | 6 | 9 |
P/E ratio |
16.08 | 15.56 | 18.27 | 21.68 | 24.69 | 28.77 | 27.39 | 16.78 | 34.63 | 22.24 |
P/S ratio |
4.71 | 5.26 | 6.03 | 6.80 | 7.43 | 7.31 | 8.56 | 7.38 | 7.12 | 6.82 |
Altman Z-Score |
36.25 | 28.36 | 28.77 | 25.99 | 28.83 | 23.54 | 30.64 | 20.37 | 15.40 | 26.77 |
Altman Z″-Score (non-manufacturers) |
47.39 | 33.27 | 27.94 | 21.31 | 21.52 | 19.59 | 19.65 | 16.86 | 13.10 | 18.07 |
P/FCF ratio |
12.66 | 14.73 | 14.00 | 17.49 | 0.00 | 0.00 | 0.00 | 17.92 | 19.27 | 23.86 |
Beneish M-Score |
(2.68) | (2.12) | (3.06) | (2.85) | (2.59) | (3.08) | (2.23) | (2.37) | (3.00) | (2.83) |
P/Operating CF |
52.15 | 73.32 | 56.82 | 62.60 | 73.13 | 53.37 | 71.17 | 69.13 | 64.30 | 79.12 |
P/B ratio |
1.52 | 1.83 | 2.36 | 3.11 | 3.40 | 3.00 | 3.97 | 3.48 | 3.77 | 3.87 |
Dividend Safety Score |
82 | — | — | — | — | — | — | — | — | — |
Price to Tangible BV |
1.74 | 2.13 | 2.76 | 3.93 | 4.84 | 4.77 | 7.05 | 5.12 | 6.38 | 7.14 |
EV/Sales |
2.51 | 3.26 | 4.20 | 5.38 | 6.21 | 6.11 | 7.67 | 6.18 | 6.18 | 6.17 |
EV/EBITDA |
6.70 | 8.11 | 9.12 | 10.47 | 11.65 | 12.32 | 14.67 | 12.00 | 11.75 | 12.75 |
EV/Operating CF |
6.57 | 8.99 | 9.47 | 13.31 | 14.37 | 12.80 | 21.09 | 15.43 | 15.13 | 16.69 |
EV/FCF |
6.74 | 9.12 | 9.75 | 13.85 | (873.06) | (149.60) | (80.21) | 15.02 | 16.72 | 21.60 |
Quick Ratio |
34.36 | 23.18 | 20.44 | 13.52 | 17.65 | 14.69 | 13.78 | 10.47 | 8.25 | 9.79 |
Current Ratio |
37.62 | 25.64 | 22.56 | 15.09 | 19.53 | 16.42 | 15.92 | 11.58 | 9.32 | 11.41 |
Net Debt/EBITDA |
(5.95) | (5.05) | (4.01) | (2.79) | (2.33) | (2.47) | (1.75) | (2.36) | (1.83) | (1.39) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.31 | 0.32 | 0.39 | 0.44 | 0.43 | 0.38 | 0.45 | 0.44 | 0.49 | 0.51 |
Operating CF/Net income |
1.30 | 1.07 | 1.34 | 1.28 | 1.43 | 1.86 | 1.16 | 0.91 | 1.99 | 1.20 |
Capex/Depreciation |
(0.12) | (0.07) | (0.10) | (0.12) | (0.08) | (0.12) | (3.13) | 0.16 | (0.58) | (1.17) |
Interest Coverage |
— | — | — | 29.94 | 113.73 | 122.39 | 69.42 | 86.16 | 1,118.29 | 1,348.92 |
| 9.54% | 11.29% | 13.72% | 14.88% | 14.09% | 10.59% | 15.50% | 22.21% | 11.54% | 17.46% | |
| 9.21% | 10.76% | 12.83% | 13.76% | 13.01% | 9.75% | 14.06% | 19.28% | 10.07% | 15.61% | |
ROIC |
21.26% | 24.66% | 29.58% | 31.55% | 25.56% | 16.72% | 18.90% | 30.85% | 31.13% | 23.59% |
Return on Tangible Assets |
10.74% | 13.56% | 14.84% | 17.49% | 18.48% | 15.47% | 23.69% | 28.11% | 15.32% | 29.28% |
Average Days of Receivables |
33.37 | 36.53 | 24.64 | 38.66 | 38.19 | 35.52 | 36.90 | 34.38 | 31.93 | 29.82 |
Research and Development Expense of Revenue |
1.73% | 1.99% | 1.12% | 0.94% | 1.07% | 1.15% | 1.03% | 1.08% | 1.08% | 1.21% |
Selling, General and Administrative Expense of Revenue |
25.78% | 23.80% | 25.29% | 22.79% | 23.47% | 26.92% | 24.20% | 17.04% | 16.75% | 17.88% |
Intangible Assets out of Total Assets |
0.12 | 0.13 | 0.14 | 0.19 | 0.28 | 0.34 | 0.40 | 0.29 | 0.34 | 0.42 |
Share Based Compensation of Revenue |
0.97% | 0.63% | 0.45% | 0.35% | 0.34% | 0.38% | 0.24% | 0.15% | 0.31% | 0.23% |
Graham Net Nets |
0.52 | 0.42 | 0.33 | 0.23 | 0.18 | 0.17 | 0.12 | 0.16 | 0.12 | 0.10 |
Graham Number |
53.69 | 54.58 | 60.30 | 56.46 | 51.74 | 43.05 | 49.08 | 51.55 | 32.90 | 36.51 |
Earnings Yield |
6.22% | 6.43% | 5.47% | 4.61% | 4.05% | 3.48% | 3.65% | 5.96% | 2.89% | 4.50% |
Free Cash Flow Yield |
7.90% | 6.79% | 7.14% | 5.72% | (0.10%) | (0.56%) | (1.12%) | 5.58% | 5.19% | 4.19% |
Revenue per Share |
11.89 | 11.68 | 13.84 | 14.37 | 13.45 | 11.53 | 12.61 | 11.26 | 11.14 | 10.48 |
Operating CF per Share |
4.53 | 4.23 | 6.14 | 5.81 | 5.81 | 5.50 | 4.58 | 4.51 | 4.55 | 3.87 |
Capex per Share |
(0.11) | (0.06) | (0.18) | (0.22) | (0.15) | (0.24) | (5.79) | 0.12 | (0.43) | (0.88) |
Free Cash Flow per Share |
4.42 | 4.17 | 5.96 | 5.59 | 5.66 | 5.27 | (1.21) | 4.64 | 4.12 | 2.99 |
Cash per Share |
26.47 | 23.69 | 25.59 | 20.64 | 16.72 | 14.10 | 11.50 | 13.70 | 10.75 | 7.03 |
Shareholders Equity per Share |
36.81 | 33.52 | 35.36 | 31.41 | 29.38 | 28.11 | 27.17 | 23.86 | 21.01 | 18.46 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
36.81 | 33.52 | 35.36 | 31.41 | 29.38 | 28.11 | 27.17 | 23.86 | 21.01 | 18.46 |
Free Cash Flow |
14.32 | 14.62 | 21.64 | 20.33 | 20.65 | 19.28 | (4.48) | 17.29 | 15.31 | 11.23 |
Working Capital |
95.14 | 92.57 | 101.56 | 83.96 | 69.41 | 58.47 | 51.44 | 55.64 | 43.91 | 31.45 |
Capital Expenditures |
(0.37) | (0.21) | (0.64) | (0.82) | (0.55) | (0.86) | (21.54) | 0.46 | (1.60) | (3.30) |
Net Current Asset Value |
94.47 | 91.22 | 99.12 | 80.30 | 64.66 | 53.34 | 46.19 | 50.13 | 34.57 | 27.53 |
EV/EBIT |
8.47 | 9.81 | 12.58 | 14.22 | 16.14 | 18.80 | 20.40 | 13.89 | 13.46 | 14.98 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.46 | (0.01) | 0.04 | 0.08 |
Price to Operating Income |
15.90 | 15.84 | 18.06 | 17.97 | 19.32 | 22.50 | 22.77 | 16.57 | 15.51 | 16.55 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.30 | 0.29 | 0.60 | 0.69 | 0.69 | 0.64 | 0.64 | 0.29 | 0.24 | 0.28 |
Cash ROIC |
6.99% | 7.30% | 9.78% | 10.74% | 12.28% | 12.48% | (3.12%) | 12.34% | 12.97% | 11.74% |
Accounts Receivable Turnover |
10.12 | 10.93 | 11.25 | 9.80 | 10.62 | 9.54 | 10.79 | 11.08 | 12.12 | 10.11 |
Accounts Payable Turnover |
20.56 | 22.88 | 20.32 | 20.30 | 23.42 | 17.64 | 16.82 | 16.44 | 16.33 | 20.07 |
Inventory Turnover |
1.97 | 1.82 | 2.19 | 2.61 | 2.83 | 2.53 | 2.83 | 2.95 | 3.07 | 3.57 |
Average Days of Payables |
20.13 | 15.16 | 13.90 | 22.13 | 15.31 | 17.30 | 22.98 | 22.68 | 22.70 | 21.19 |
Days of Inventory on Hand |
175.33 | 191.91 | 173.26 | 160.17 | 132.74 | 136.56 | 144.72 | 125.88 | 127.44 | 106.22 |
Average Receivables |
3.81 | 3.74 | 4.46 | 5.34 | 4.62 | 4.42 | 4.35 | 3.79 | 3.42 | 3.89 |
Average Payables |
0.80 | 0.73 | 0.99 | 0.99 | 0.77 | 0.94 | 1.04 | 0.95 | 0.92 | 0.78 |
Average Inventory |
8.37 | 9.20 | 9.20 | 7.71 | 6.41 | 6.57 | 6.16 | 5.33 | 4.89 | 4.37 |
Average Assets |
122.54 | 129.00 | 129.67 | 119.76 | 113.69 | 110.77 | 104.78 | 96.26 | 84.47 | 77.68 |
Average Common Equity |
118.35 | 122.87 | 121.28 | 110.70 | 104.98 | 101.96 | 95.04 | 83.56 | 73.68 | 69.45 |
Columns are period end dates